These findings underscore the potential of nutraceutical synergies to optimize therapeutic outcomes while reducing pharmaceutical dosages and minimizing side effects
Current Evidence for Efficacy Preclinical Studies The majority of evidence supporting the therapeutic efficacy of BPC-157 and TB-500 derives from extensive preclinical investigations conducted in various experimental models
Many researchers believe that maintaining adequate antioxidant levels, including glutathione, may support a healthy environment for the placenta to function
In other antioxidant compounds, this has been achieved by using various nanoformulations, which increase stability and solubilization, increase uptake into cells, improve accessibility to otherwise difficult to reach targets, and increase time spent in the circulation [1821]
[24] Although glutamine is metabolized to glutamate and ammonia, both of which have neurological effects, their concentrations are not increased much, and no adverse neurological effects were detected